Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China
· Delayed Price · Currency is CNY 57.53
-0.59 (-1.02%)
At close: Mar 9, 2026
Hangzhou AGS MedTech Revenue
In the year 2025, Hangzhou AGS MedTech had annual revenue of 597.21M CNY, down -6.19%. Hangzhou AGS MedTech had revenue of 137.88M in the quarter ending December 31, 2025, a decrease of -34.15%.
Revenue
597.21M
Revenue Growth
-6.19%
P/S Ratio
7.78
Revenue / Employee
802.70K
Employees
856
Market Cap
4.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 597.21M | -39.43M | -6.19% |
| Dec 31, 2024 | 636.63M | 127.89M | 25.14% |
| Dec 31, 2023 | 508.75M | 137.64M | 37.09% |
| Dec 31, 2022 | 371.11M | 65.65M | 21.49% |
| Dec 31, 2021 | 305.47M | 133.51M | 77.64% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medprin Regenerative Medical Technologies | 336.73M |
| Zhejiang Orient Gene Biotech | 958.99M |
| CareRay Digital Medical Technology | 320.53M |
| Shanghai Kinetic Medical | 1.02B |
| Nanjing Medlander Medical Technology | 431.59M |
| Getein Biotech | 1.04B |
| GKHT Medical Technology | 7.22B |
| Wuhan Huakang Century Clean Technology | 2.06B |